160 related articles for article (PubMed ID: 24451298)
1. Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
Curtis S; Hong S; Gucalp R; Calvo M
Am J Ther; 2016; 23(1):e321-3. PubMed ID: 24451298
[TBL] [Abstract][Full Text] [Related]
2. Recurrent lower extremity pseudocellulitis.
Korniyenko A; Lozada J; Ranade A; Sandhu G
Am J Ther; 2012 Jul; 19(4):e141-2. PubMed ID: 22772033
[TBL] [Abstract][Full Text] [Related]
3. A rash diagnosis: Gemcitabine-associated pseudocellulitis.
Strouse C; Epperla N
J Oncol Pharm Pract; 2017 Mar; 23(2):157-160. PubMed ID: 26946530
[TBL] [Abstract][Full Text] [Related]
4. Recurrent pseudocellulitis due to gemcitabine: underrecognized and underreported?
Dasanu CA; Bockorny B
J Oncol Pharm Pract; 2015 Oct; 21(5):377-9. PubMed ID: 24769519
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
Bami H; Goodman C; Boldt G; Vincent M
Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature.
Tan DH; Bunce PE; Liles WC; Gold WL
Clin Infect Dis; 2007 Sep; 45(5):e72-6. PubMed ID: 17682983
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure: A Systematic Review.
Kovacs LD; O'Donoghue M; Cogen AL
JAMA Dermatol; 2023 Aug; 159(8):870-874. PubMed ID: 37379014
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-associated "pseudocellulitis" and "pseudosepsis": a case report and review of the literature.
Obeid KM; Venugopal AA
Am J Ther; 2013 Jan; 20(1):118-20. PubMed ID: 21768869
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine associated pseudocellulitis: A missed diagnosis.
Gill D; Schrader J; Kelly M; Martinez F; Syed W; Wright J
J Oncol Pharm Pract; 2018 Oct; 24(7):550-552. PubMed ID: 28714381
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine associated pseudocellulitis.
Singh A; Hampole H
J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
[No Abstract] [Full Text] [Related]
11. Gemcitabine-induced pseudocellulitis.
Caplan A; Chu DH; Rosenbach M; Svoboda J
Cutis; 2018 Nov; 102(5):E20-E23. PubMed ID: 30566560
[No Abstract] [Full Text] [Related]
12. A case of gemcitabine-related acute lipodermatosclerosis.
Nyckowski T; McGregor S; Huang WW
J Oncol Pharm Pract; 2019 Jul; 25(5):1271-1274. PubMed ID: 30041585
[TBL] [Abstract][Full Text] [Related]
13. Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases.
Brandes A; Reichmann U; Plasswilm L; Bamberg M
Anticancer Drugs; 2000 Jan; 11(1):15-7. PubMed ID: 10757558
[TBL] [Abstract][Full Text] [Related]
14. Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
Li J; Ko CJ; Saif MW
Cutan Ocul Toxicol; 2009; 28(3):144-8. PubMed ID: 19527102
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine: cutaneous, hepatic and vascular disorders.
Prescrire Int; 2009 Jun; 18(101):122. PubMed ID: 19637433
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.
Kuku I; Kaya E; Sevinc A; Aydogdu I
J Eur Acad Dermatol Venereol; 2002 May; 16(3):271-2. PubMed ID: 12195570
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy.
Schwartz BM; Khuntia D; Kennedy AW; Markman M
Gynecol Oncol; 2003 Nov; 91(2):421-2. PubMed ID: 14599876
[TBL] [Abstract][Full Text] [Related]
18. Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine.
Retrosi C; Vezzoni R; Conforti C; Corneli P; Magaton-Rizzi G; Zalaudek I; Di Meo N
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Dec; 28(4):185-186. PubMed ID: 31855275
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine-induced acute lipodermatosclerosis-like reaction.
Chu CY; Yang CH; Chiu HC
Acta Derm Venereol; 2001; 81(6):426-8. PubMed ID: 11859947
[TBL] [Abstract][Full Text] [Related]
20. Widespread Skin Necrosis Secondary to Gemcitabine Therapy.
Zito PM; Gonzalez AM; Fox JD; Cronin M; Mackrides N; Kirsner RS; Nichols AJ
J Drugs Dermatol; 2018 May; 17(5):582-585. PubMed ID: 29742194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
